Login / Signup

Hidradenitis suppurativa and polycystic ovarian syndrome: Systematic review and meta-analysis.

Kevin PhanOlivia A CharltonSaxon D Smith
Published in: The Australasian journal of dermatology (2019)
In summary, pooled analysis of existing case-control studies supports a significant association between hidradenitis suppurativa and polycystic ovarian syndrome. Our results imply that hidradenitis suppurativa patients with signs of hyperandrogenism may benefit from screening for polycystic ovarian syndrome, and may potentially benefit from anti-androgen therapy.
Keyphrases
  • hidradenitis suppurativa
  • case control
  • case report
  • type diabetes
  • randomized controlled trial
  • metabolic syndrome
  • clinical trial
  • adipose tissue
  • skeletal muscle
  • cell therapy
  • smoking cessation
  • replacement therapy